Evidence map›Paper›PMID 19322168›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2009

Clozapine interaction with phosphatidyl inositol 3-kinase (PI3K)/insulin-signaling pathway in Caenorhabditis elegans.

Rakesh Karmacharya, Gregory R Sliwoski, Miriam Y Lundy, Raymond F Suckow, Bruce M Cohen, Edgar A Buttner

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biomolecules · 2022
    Review
  8. Metabolic and behavioral effects of olanzapine and fluoxetine on the model organismSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  9. Article
  10. Frontiers in endocrinology · 2020
    Review
  11. Article
  12. Review
  13. Review
  14. Crossing the Worm-Brain Barrier by UsingMolecular neuropsychiatry · 2018
    Review
  15. Article
  16. Article
  17. Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  18. Forward Genetic Screen inFrontiers in molecular neuroscience · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rakesh KarmacharyaDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA.
Gregory R Sliwoski
Miriam Y Lundy
Raymond F Suckow
Bruce M Cohen
Edgar A Buttner
McLean Hospital · USHarvard University · USNew York State Psychiatric Institute

Funding

Functional Genomics of C.elegans Used To Study DiseaseK08NS002083 · NINDS · MC LEAN HOSPITAL (BELMONT, MA) · PI BUTTNER, EDGAR A · 2001 to 2006
$668k
NINDS NIH HHS K08 NS002083
6 · The paper itself

Abstract

Clozapine has superior and unique effects as an antipsychotic agent, but the mediators of these effects are not known. We studied behavioral and developmental effects of clozapine in Caenorhabditis elegans, as a model system to identify previously undiscovered mechanisms of drug action. Clozapine induced early larval arrest, a phenotype that was also seen with the clozapine metabolite N-desmethyl clozapine but not with any other typical or atypical antipsychotic drug tested. Mutations in the insulin receptor/daf-2 and phosphatidyl inositol 3-kinase (PI3K)/age-1 suppressed clozapine-induced larval arrest, suggesting that clozapine may activate the insulin-signaling pathway. Consistent with this notion, clozapine also increased the expression of an age-1::GFP reporter. Activation of the insulin-signaling pathway leads to cytoplasmic localization of the fork head transcription factor FOXO/daf-16. Clozapine produced cytoplasmic localization of DAF-16::GFP in arrested L1 larvae, in contrast to stressors such as starvation or high temperature, which produce nuclear localization of DAF-16::GFP in arrested L1 larvae. Clozapine also inhibited pharyngeal pumping in C. elegans, an effect that may contribute to, but did not explain, clozapine-induced larval arrest. Our findings demonstrate a drug-specific interaction between clozapine and the PI3K/insulin-signaling pathway in C. elegans. As this pathway is conserved across species, the results may have implications for understanding the unique effects of clozapine in humans.

Indexed as

AnimalsAntipsychotic AgentsCaenorhabditis elegansCaenorhabditis elegans ProteinsClozapineConserved SequenceEvolution, MolecularForkhead Transcription FactorsGenes, ReporterGreen Fluorescent ProteinsGrowth InhibitorsInsulinLarvaModels, AnimalPharynxPhosphatidylinositol 3-KinasesAGE-1 protein, C elegansAntipsychotic AgentsCaenorhabditis elegans ProteinsClozapinedaf-16 protein, C elegansForkhead Transcription FactorsGreen Fluorescent ProteinsGrowth InhibitorsInsulinPhosphatidylinositol 3-KinasesReceptor, InsulinTranscription Factors

Identifiers

PMID19322168
PMCPMC3348699
OpenAlexW2039685201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.